Solid focal liver lesions: Dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine

被引:20
作者
Grazioli L. [1 ]
Bondioni M.P. [1 ]
Faccioli N. [2 ]
Gambarini S. [1 ]
Tinti R. [1 ]
Schneider G. [3 ]
Kirchin M. [4 ]
机构
[1] Department of Radiology, University of Brescia, Brescia
[2] Department of Radiology, University of Verona, Verona
[3] Department of Radiology, University of Homburg, Saarland
[4] Bracco Medical Imaging, Milan
关键词
contrast media; liver; magnetic resonance imaging; meglumine;
D O I
10.1007/s12029-010-9145-0
中图分类号
学科分类号
摘要
Introduction: The purpose of this paper is to illustrate contrast enhancement patterns of solid focal liver lesions on dynamic and late phase imaging with gadobenate dimeglumine (Gd-BOPTA). Imaging Findings: Unenhanced T2- and T1-weighted, dynamic T1-weighted (arterial, portal-venous, and equilibrium) and late phase (1-3 h) Gd-BOPTA-enhanced MR imaging of different focal liver lesions (nodular regenerative hyperplasia, hepatic adenoma, liver adenomatosis, hepatocellular carcinoma, peripheral cholangiocarcinoma, hypervascular metastases, and hypovascular metastases) are shown. Dynamic imaging was performed using GRE T1-w sequences after the bolus injection of 0.1 mmol/kg Gd-BOPTA; late-phase imaging was obtained at 1-3 h after contrast injection. Conclusions: Dynamic imaging with Gd-BOPTA provides the same information as with conventional gadolinium-based extracellular contrast agents, while late-phase imaging gives additional information for lesion identification and characterization. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码:221 / 232
页数:11
相关论文
共 46 条
[31]  
Sakamoto M., Hirohashi S., Shimosato Y., Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma, Human Pathol, 22, pp. 172-8, (1991)
[32]  
Choi B.I., Takayasu K., Han M.C., Small hepatocellular carcinomas and associated nodular lesions of the liver: Pathology, pathogenesis, and imaging findings, AJR Am J Roentgenol, 160, pp. 1177-87, (1993)
[33]  
Noguchi S., Yamamoto R., Tatsuta M., Et al., Cell features and patterns in fine-needle aspirates of hepatocellular carcinoma, Cancer, 58, pp. 321-8, (1986)
[34]  
Manfredi R., Maresca G., Baron R.L., Cotroneo A.R., De Gaetano A.M., De Franco A., Pirovano G., Spinazzi A., Marano P., Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA), Journal of Magnetic Resonance Imaging, 9, 5, pp. 704-710, (1999)
[35]  
Craig J.R., Peters R.L., Edmonson H.A., Tumors of the Liver and Intrahepatic Bile Ducts: Atlas of Tumor Pathology, (1989)
[36]  
Maetani Y., Itoh K., Watanabe C., Et al., MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation, AJR Am J Roentgenol, 176, pp. 1499-507, (2001)
[37]  
Vilgrain V., Van Beers B.E., Flejou J.-F., Belghiti J., Delos M., Gautier A.-L., Zins M., Denys A., Menu Y., Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients, Journal of Computer Assisted Tomography, 21, 1, pp. 59-65, (1997)
[38]  
Murakami T., Nakamura H., Tsuda K., Et al., Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: Pathologic correlation study, J Magn Reson Imaging., 5, pp. 165-70, (1995)
[39]  
Zhang Y., Uchida M., Abe T., Nishimura H., Hayabuchi N., Nakashima Y., Intrahepatic peripheral cholangiocarcinoma: Comparison of dynamic CT and dynamic MRI, Journal of Computer Assisted Tomography, 23, 5, pp. 670-677, (1999)
[40]  
Ohsawa M., Aozasa K., Horiuchi K., Et al., Malignant lymphoma of the liver, Dig Dis Sci, 37, pp. 1105-9, (1992)